首頁 > 市場調查報告書 > 製藥

循環系統

充血性心臟衰竭的全球市場 - 市場佔有率·規模·趨勢·產業分析:各產品，各最終用途，各地區，市場區隔預測(2022年～2030年)

市場調查報告書

商品編碼

1150063

充血性心臟衰竭的全球市場 - 市場佔有率·規模·趨勢·產業分析:各產品，各最終用途，各地區，市場區隔預測(2022年～2030年)

Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product ; By End-Use; By Region; Segment Forecast, 2022 - 2030

出版日期: 2022年10月01日 | 出版商:

Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球充血性心臟衰竭的市場規模在2030年前將達到184億8,000萬美元。

本報告提供全球充血性心臟衰竭市場調查，提供市場概要，市場規模和預測，趨勢，促進因素·阻礙因素，各產品·各最終用途·各地區等分析，再加上企業簡介等資訊。

充血性心臟衰竭市場 - 產業的概述
充血性心臟衰竭市場動態
- 促進因素和機會
- 阻礙因素與課題
波特的五力分析
- 供給企業談判力
- 新加入廠商者的威脅
- 買方議價能力
- 替代品的威脅
- 現有企業間的競爭力
大環境分析
充血性心臟衰竭的產業趨勢
價值鏈分析
COVID-19影響分析

第5章全球充血性心臟衰竭市場:各產品

主要調查結果
簡介
- 全球充血性心臟衰竭，各產品(2018年～2030年)
心室輔助裝置
- 全球充血性心臟衰竭市場，心室輔助裝置，各地區(2018年～2030年)
植入式心臟整流去顫器(ICD)
- 全球充血性心臟衰竭市場，植入式心臟整流去顫器(ICD)，各地區(2018年～2030年)
心律調節器
- 全球充血性心臟衰竭市場，心律調節器，各地區(2018年～2030年)
心臟再同步化治療
- 全球充血性心臟衰竭市場，心臟再同步化治療，各地區(2018年～2030年)
反搏動裝置
- 全球充血性心臟衰竭市場，計數器pulsation各設備，各地區(2018年～2030年)

第6章全球充血性心臟衰竭市場:各最終用途

主要調查結果
簡介
- 全球充血性心臟衰竭市場，各最終用途(2018年～2030年)
醫院·診所
- 全球充血性心臟衰竭市場，醫院·診所，各地區(2018年～2030年)
心血管疾病專門治療中心
- 全球充血性心臟衰竭市場，心血管疾病專門治療中心，各地區(2018年～2030年)
門診病人手術中心
- 全球充血性心臟衰竭市場，門診病人手術中心，各地區(2018年～2030年)

第7章全球充血性心臟衰竭市場:各地區

主要調查結果
簡介
- 充血性心臟衰竭市場評估，各地區(2018年～2030年)
充血性心臟衰竭市場 - 北美
- 北美:充血性心臟衰竭市場，各最終用途(2018年～2030年)
- 北美:充血性心臟衰竭市場，各產品(2018年～2030年)
- 充血性心臟衰竭市場 - 美國
- 充血性心臟衰竭市場 - 加拿大
充血性心臟衰竭市場 - 歐洲
- 歐洲:充血性心臟衰竭市場，各最終用途(2018年～2030年)
- 歐洲:充血性心臟衰竭市場，各產品(2018年～2030年)
- 充血性心臟衰竭市場 - 英國
- 充血性心臟衰竭市場 - 法國
- 充血性心臟衰竭市場 - 德國
- 充血性心臟衰竭市場 - 義大利
- 充血性心臟衰竭市場 - 西班牙
- 充血性心臟衰竭市場 - 荷蘭
- 充血性心臟衰竭市場 - 俄羅斯
充血性心臟衰竭市場 - 亞太地區
- 亞太地區:充血性心臟衰竭市場，各最終用途(2018年～2030年)
- 亞太地區:充血性心臟衰竭市場，各產品(2018年～2030年)
- 充血性心臟衰竭市場 - 中國
- 充血性心臟衰竭市場 - 印度
- 充血性心臟衰竭市場 - 馬來西亞
- 充血性心臟衰竭市場 - 日本
- 充血性心臟衰竭市場 - 印尼
- 充血性心臟衰竭市場 - 韓國
充血性心臟衰竭市場 - 中東·非洲
- 中東·非洲:充血性心臟衰竭市場，各最終用途(2018年～2030年)
- 中東·非洲:充血性心臟衰竭市場，各產品(2018年～2030年)
- 充血性心臟衰竭市場 - 沙烏地阿拉伯
- 充血性心臟衰竭市場 - 阿拉伯聯合大公國
- 充血性心臟衰竭市場 - 以色列
- 充血性心臟衰竭市場 - 南非
充血性心臟衰竭市場 - 南美
- 南美:充血性心臟衰竭市場，各最終用途(2018年～2030年)
- 南美:充血性心臟衰竭市場，各產品(2018年～2030年)
- 充血性心臟衰竭市場 - 墨西哥
- 充血性心臟衰竭市場 - 巴西
- 充血性心臟衰竭市場 - 阿根廷

第8章競爭情形

擴大·收購的分析
- 擴大
- 收購
夥伴關係/合作/協定/公開

第9章企業簡介

ABIOMED
Berlin Heart
Abbot Laboratories
Aspect Imaging Ltd
Siemens
General Electric
Hitachi
Koninklijke Philips
Neusoft Corporation
ESAOTE
Medtronic
OMRON Corporation
Dexcom
Masimo
Jarvik Heart
Biotronik
Teleflex
Jude Medical
Lepu Medical
Osypka Medical GmbH
Medtronic
Boston Scientific Corporation

簡介目錄圖表

Product Code: PM1321

The global congestive heart failure market size is expected to reach USD 18.48 billion by 2030, according to a new study by Polaris Market Research. The report "Congestive Heart Failure Market Share, Size, Trends, Industry Analysis Report, By Product (Cardiac Resynchronization Therapy, Counter Pulsation Devices, ICD, Pacemakers, Ventricular Assist Devices, Others); By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Congestive heart failure is becoming more prevalent, in part due to the rise in coronary artery disease and heart attacks worldwide. According to the World Health Organization's 2021 report, cardiovascular diseases (CVDs), which accounted for 17.9 million deaths worldwide in 2019 (32% of all fatalities), were the cause of 32% of all deaths. Furthermore, the American Heart Association predicts that by 2030, even more Americans than the present 22.2 million will have heart disease.

Due to the rising prevalence of CVDs and the increased need for treatment devices, the market will soon grow. Market leaders take part in new launches, partnerships, expansions, and acquisitions to stay competitive. For instance, Abbott's EnSite X EP System, which uses EnSite omnipolar technology to treat cardiac arrhythmias, received FDA approval in the U.S., in January 2022.

COVID-19 pandemic reportedly had a negative impact on people with underlying cardiovascular disease, particularly those who had previously experienced an acute cardiac injury. A research by Tarun Dalia et al., published in February 2021, found that congestive heart failure (CHF), which is present in individuals with COVID-19, is related to worse outcomes and higher mortality. Additionally, cardiac arrhythmia and abrupt cardiac injury are more likely to occur in people who have severe COVID-19 and non-survivor circumstances.

An increase in cardiovascular patients, an ageing population, insurance coverage, and technological developments like proprietary algorithms that accurately detect and reduce the incidence of atrial fibrillation are some of the main factors influencing the growth of implantable pacemakers. According to the United Nations Department of Economic and Social Affairs' research on world population ageing.

In 2020, there were 727 million people over the age of 65 in the world. Over the next three decades, the number of older people worldwide is predicted to more than quadruple, reaching over 1.5 billion in 2050. This is because an ageing population is more prone to chronic diseases, such as cardiovascular diseases, which are likely to increase during the projection period.

Congestive Heart Failure Market Report Highlights

In 2021, the market for congestive heart failure is expected to be dominated by pacemaker devices. Congestive heart failure therapeutic devices for the treatment of heart failure are in higher demand, pacemaker use is increasing, and pharmaceutical and medical device R&D are all contributing to the expansion of this market.

In 2021, hospital systems made up the majority of this market. This hospital segment has expanded as a result of the rising patient population and the significant concentration of trained workers in hospital settings. Additionally, hospitals support the reduction of adverse patient reactions during crucial medical procedures.

The majority of the market was controlled by North America. Rising cases of target illnesses, better public knowledge of the heart related ailments are few regional drivers.

The global players with global presence include ABIOMED, LivaNova, Jarvik Heart Inc., Berlin Heart, Abbot Laboratories, Aspect Imaging Ltd, CANON MEDICAL SYSTEMS CORPORATION, and Siemens.

Polaris Market Research has segmented the congestive heart failure market report based on product, end-use, and region:

Congestive Heart Failure, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Ventricular Assist Devices

Implantable Cardioverter Defibrillators (ICD)

Pacemakers

Cardiac Resynchronization Therapy

Counter Pulsation Devices

Congestive Heart Failure, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals and clinic

Specialized Cardiovascular Disease Treatment centers

Ambulatory surgery centers

Congestive Heart Failure, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Congestive Heart Failure Market Insights

4.1. Congestive Heart Failure Market - Industry Snapshot
4.2. Congestive Heart Failure Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
  - 4.2.1.2. Growing geriatric population base
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of devices
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Congestive Heart Failure Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Congestive Heart Failure Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Congestive Heart Failure, by Product, 2018 - 2030 (USD Billion)
5.3. Ventricular Assist Devices
- 5.3.1. Global Congestive Heart Failure Market, by Ventricular Assist Devices, by Region, 2018 - 2030 (USD Billion)
5.4. Implantable Cardioverter Defibrillators (ICD)
- 5.4.1. Global Congestive Heart Failure Market, by Implantable Cardioverter Defibrillators (ICD), by Region, 2018 - 2030 (USD Billion)
5.5. Pacemakers
- 5.5.1. Global Congestive Heart Failure Market, by Pacemakers, by Region, 2018 - 2030 (USD Billion)
5.6. Cardiac Resynchronization Therapy
- 5.6.1. Global Congestive Heart Failure Market, by Cardiac Resynchronization Therapy, by Region, 2018 - 2030 (USD Billion)
5.7. Counter Pulsation Devices
- 5.7.1. Global Congestive Heart Failure Market, by Counter Pulsation Devices, by Region, 2018 - 2030 (USD Billion)

6. Global Congestive Heart Failure Market, by End-Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
6.3. Hospitals & Clinic
- 6.3.1. Global Congestive Heart Failure Market, by Hospitals & Clinic, by Region, 2018 - 2030 (USD Billion)
6.4. Specialized Cardiovascular Disease Treatment Centres
- 6.4.1. Global Congestive Heart Failure Market, by Specialized Cardiovascular Disease Treatment Centres, by Region, 2018 - 2030 (USD Billion)
6.5. Ambulatory Surgery Centres
- 6.5.1. Global Congestive Heart Failure Market, by Ambulatory Surgery Centres, by Region, 2018 - 2030 (USD Billion)

7. Global Congestive Heart Failure Market, by Geography

7.1. Key findings
7.2. Introduction
- 7.2.1. Congestive Heart Failure Market Assessment, By Geography, 2018 - 2030 (USD Billion)
7.3. Congestive Heart Failure Market - North America
- 7.3.1. North America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.3.2. North America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.3.3. Congestive Heart Failure Market - U.S.
  - 7.3.3.1. U.S.: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.3.3.2. U.S.: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.3.4. Congestive Heart Failure Market - Canada
  - 7.3.4.1. Canada: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.3.4.2. Canada: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
7.4. Congestive Heart Failure Market - Europe
- 7.4.1. Europe: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.4.2. Europe: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.3. Congestive Heart Failure Market - UK
  - 7.4.3.1. UK: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.3.2. UK: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.4. Congestive Heart Failure Market - France
  - 7.4.4.1. France: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.4.2. France: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.5. Congestive Heart Failure Market - Germany
  - 7.4.5.1. Germany: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.5.2. Germany: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.6. Congestive Heart Failure Market - Italy
  - 7.4.6.1. Italy: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.6.2. Italy: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.7. Congestive Heart Failure Market - Spain
  - 7.4.7.1. Spain: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.7.2. Spain: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.8. Congestive Heart Failure Market - Netherlands
  - 7.4.8.1. Netherlands: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.8.2. Netherlands: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.4.9. Congestive Heart Failure Market - Russia
  - 7.4.9.1. Russia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.4.9.2. Russia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
7.5. Congestive Heart Failure Market - Asia Pacific
- 7.5.1. Asia Pacific: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.5.2. Asia Pacific: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.3. Congestive Heart Failure Market - China
  - 7.5.3.1. China: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.3.2. China: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.4. Congestive Heart Failure Market - India
  - 7.5.4.1. India: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.4.2. India: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.5. Congestive Heart Failure Market - Malaysia
  - 7.5.5.1. Malaysia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.5.2. Malaysia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.6. Congestive Heart Failure Market - Japan
  - 7.5.6.1. Japan: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.6.2. Japan: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.7. Congestive Heart Failure Market - Indonesia
  - 7.5.7.1. Indonesia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.7.2. Indonesia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.5.8. Congestive Heart Failure Market - South Korea
  - 7.5.8.1. South Korea: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.5.8.2. South Korea: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
7.6. Congestive Heart Failure Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.6.2. Middle East & Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.6.3. Congestive Heart Failure Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.6.4. Congestive Heart Failure Market - UAE
  - 7.6.4.1. UAE: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.6.4.2. UAE: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.6.5. Congestive Heart Failure Market - Israel
  - 7.6.5.1. Israel: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.6.5.2. Israel: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.6.6. Congestive Heart Failure Market - South Africa
  - 7.6.6.1. South Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.6.6.2. South Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
7.7. Congestive Heart Failure Market - Latin America
- 7.7.1. Latin America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
- 7.7.2. Latin America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.7.3. Congestive Heart Failure Market - Mexico
  - 7.7.3.1. Mexico: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.7.3.2. Mexico: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.7.4. Congestive Heart Failure Market - Brazil
  - 7.7.4.1. Brazil: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.7.4.2. Brazil: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
- 7.7.5. Congestive Heart Failure Market - Argentina
  - 7.7.5.1. Argentina: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
  - 7.7.5.2. Argentina: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. ABIOMED
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Berlin Heart
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Abbot Laboratories
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Aspect Imaging Ltd
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Siemens
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. General Electric
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Hitachi
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Koninklijke Philips
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Neusoft Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. ESAOTE
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Medtronic
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. OMRON Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Dexcom
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. Masimo
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
9.15. Jarvik Heart
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
9.16. Biotronik
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
9.17. Teleflex
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
9.18. Jude Medical
- 9.18.1. Company Overview
- 9.18.2. Financial Performance
- 9.18.3. Product Benchmarking
- 9.18.4. Recent Development
9.19. Lepu Medical
- 9.19.1. Company Overview
- 9.19.2. Financial Performance
- 9.19.3. Product Benchmarking
- 9.19.4. Recent Development
9.20. Osypka Medical GmbH
- 9.20.1. Company Overview
- 9.20.2. Financial Performance
- 9.20.3. Product Benchmarking
- 9.20.4. Recent Development
9.21. Medtronic
- 9.21.1. Company Overview
- 9.21.2. Financial Performance
- 9.21.3. Product Benchmarking
- 9.21.4. Recent Development
9.22. Boston Scientific Corporation
- 9.22.1. Company Overview
- 9.22.2. Financial Performance
- 9.22.3. Product Benchmarking
- 9.22.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 2 Global Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 3 Congestive Heart Failure Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Table 4 North America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 5 North America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 6 U.S.: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 7 U.S.: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 8 Canada: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 9 Canada: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 10 Europe: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 11 Europe: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 12 UK: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 13 UK: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 14 France: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 15 France: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 16 Germany: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 17 Germany: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 18 Italy: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 19 Italy: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 20 Spain: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 21 Spain: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 22 Netherlands: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 23 Netherlands: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 24 Russia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 25 Russia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 26 Asia Pacific: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 27 Asia Pacific: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 28 China: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 29 China: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 30 India: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 31 India: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 32 Malaysia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 33 Malaysia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 34 Japan: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 35 Japan: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 36 Indonesia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 37 Indonesia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 38 South Korea: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 39 South Korea: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 40 Middle East & Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 41 Middle East & Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 42 Saudi Arabia: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 43 Saudi Arabia: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 44 UAE: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 45 UAE: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 46 Israel: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 47 Israel: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 48 South Africa: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 49 South Africa: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 50 Latin America: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 51 Latin America: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 52 Mexico: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 53 Mexico: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 54 Brazil: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 55 Brazil: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)
Table 56 Argentina: Congestive Heart Failure Market, by End-Use, 2018 - 2030 (USD Billion)
Table 57 Argentina: Congestive Heart Failure Market, by Product, 2018 - 2030 (USD Billion)